Clinical use of growth factors in chronic renal failure.

Abstract	Erythropoietin has been demonstrated to improve the quality of life in patients with chronic renal failure, and growth hormone has been approved for use in children with chronic renal failure and short stature as a growth promoting agent. Growth factors also have great therapeutic potential to improve glomerular function in the setting of chronic renal failure. Further studies are required to delineate the role of insulin-like growth factor I in the setting of end-stage chronic renal failure.
Authors	A Vijayan, T Behrend, S B Miller
Journal	Current opinion in nephrology and hypertension (Curr Opin Nephrol Hypertens) Vol. 9 Issue 1 Pg. 5-10 (Jan 2000) ISSN: 1062-4821 [Print] England
PMID	10654818 (Publication Type: Journal Article, Review)
Chemical References	Growth Substances Erythropoietin Human Growth Hormone
Topics	Animals Child Erythropoietin (therapeutic use) Glomerular Filtration Rate (drug effects) Growth Substances (therapeutic use) Human Growth Hormone (therapeutic use) Humans Kidney Failure, Chronic (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!